Skip to main content
. 2022 Dec 3;14(12):2710. doi: 10.3390/pharmaceutics14122710

Figure 8.

Figure 8

Comparison of the surface expression of immune ligands on HCT 116, HT-29, A2780 and A2780R. Cells were treated with Ara-C/DS, its components (50 nM Ara-C, 1 µg/mL DS) or cGAMP (1 µg/mL) for 48 h prior to analysis of (A) MHC I, (B) MICA/B and (C) ULBP2/5/6 surface expression by flow cytometry. The reported MFI was normalized to a non-stained control (data represented as the average of three independent experiments, ± SEM). Statistical analysis performed with a one-way Anova with a Tukey’s HSD for each respective cell line where *** p < 0.001, ** p < 0.01 and * p < 0.05 as compared to non-treated (NT), ^^^ p < 0.001, ^^ p < 0.01 and ^ p < 0.05 as compared to cGAMP, ### p < 0.001, ## p < 0.01 and # p < 0.05 as compared to DS.